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ABSTRACT
Constitutive heterochromatin undergoes a dynamic
clustering and spatial reorganization during myo-
genic differentiation. However the detailed mech-
anisms and its role in cell differentiation remain
largely elusive. Here, we report the identification of
a muscle-specific long non-coding RNA, ChRO1, in-
volved in constitutive heterochromatin reorganiza-
tion. ChRO1 is induced during terminal differenti-
ation of myoblasts, and is specifically localized to
the chromocenters in myotubes. ChRO1 is required
for efficient cell differentiation, with global impacts
on gene expression. It influences DNA methylation
and chromatin compaction at peri/centromeric re-
gions. Inhibition of ChRO1 leads to defects in the
spatial fusion of chromocenters, and mislocalization
of H4K20 trimethylation, Suv420H2, HP1, MeCP2 and
cohesin. In particular, ChRO1 specifically associates
with ATRX/DAXX/H3.3 complex at chromocenters to
promote H3.3 incorporation and transcriptional in-
duction of satellite repeats, which is essential for
chromocenter clustering. Thus, our results unveil a
mechanism involving a lncRNA that plays a role in
large-scale heterochromatin reorganization and cell
differentiation.
INTRODUCTION
Constitutive heterochromatin, formed mainly at the gene-
poor regions of pericentromeres and telomeres, under-
goes massive reorganization during early embryogenesis,
organogenesis and terminal differentiation of muscle and
brain (1–3). Although clustering and reorganization of con-
stitutive heterochromatin are supposed to function as a
driver of nuclear organization, the detailedmechanisms and
the relevance to gene regulation remain elusive (4,5).
Constitutive heterochromatin is characterized by high
density of repetitive DNA elements and strong enrich-
ment of trimethylation of histone H3 lysine 9 (H3K9me3).
H3K9me3, mediated by Suv39H1/2 histone methyltrans-
ferases (HMTs), has an initial role for constitutive hete-
rochromatin formation, by serving as a binding platform for
different isoforms (, ,  ) of HP1 (6). HP1 in turn recruits
DNAmethyltransferases (DNMTs) or Suv420HMTs. CpG
methylation by DNMTs and subsequent recruitment of
methyl-CpG binding proteins contribute to constitutive
heterochromatin stability (7,8). Suv420H2, the HMT for
H4K20me3, is essential for telomere homeostasis (9,10) and
required for the recruitment of the cohesin complex to the
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pericentromeric regions for proper chromosome segrega-
tion (11).
In addition to dedicated protein components, local ncR-
NAs transcribed from the repetitive DNA elements of the
pericentromere or rDNA regions participate in the chro-
matin compaction of their own origin. For example, peri-
centromeric major satellite (MajS) repeat-derived RNA
transcripts contribute to the condensation of constitutive
heterochromatin by mediating pericentromeric localization
of HP1 (12). DAXX/ATRX is a histone chaperone that is
responsible for the deposition of histone variant H3.3 at
pericentromeric and telomeric regions (13,14). While H3.3
deposition in euchromatin by HIRA complex contributes
to active transcription (15–17), H3.3 by DAXX/ATRX
is involved in heterochromatinization through RNA poly-
merase II (pol II)-dependent transcription of satellite re-
peats (13,18), which in turn promotes HP1 association and
H3K9me3 enrichment, further enhancing a positive feed-
back loop for chromatin compaction. Although the mech-
anism of heterochromatin formation at repressive domains
is relatively well investigated, the mechanism for the large-
scale reorganization associated with cell differentiation is
still unknown.
To understand the dynamic reorganization of constitu-
tive heterochromatin domains, we have analyzed myoge-
nesis as a model system. Myogenesis is characterized by
progressive ‘clustering’ of chromocenters that form a large
heterochromatin compartment (19,20). Here, we describe
the discovery of lncRNA ChRO1 that mediates constitu-
tive heterochromatin reorganization during myogenesis. In
myotubes (MT), ChRO1 brought DAXX/H3.3 to ATRX
to form a stable ATRX/DAXX/H3.3 complex at chromo-
centers for satellite RNA elevation, which led to spatial fu-
sion of chromocenters into large repressive compartments
and cell differentiation. Our results unveil a novel lncRNA,
necessary for large-scale nuclear organization and cell dif-
ferentiation, through interaction with H3.3-specific histone
chaperone complex.
MATERIALS AND METHODS
Cell culture and RNAi assays
The murine myoblast cell line C2C12 was obtained from
the American Type Culture Collection (ATCC), and main-
tained at low confluency (<50%) in Dulbecco’s-modified
Eagle’s medium (DMEM) containing 10% (v/v) fetal
bovine serum (growth medium, GM) at 37◦Cwith 5% CO2.
For differentiation of myoblasts intoMT, GMwas replaced
by DMEM containing 2% (v/v) horse serum (differenti-
ation medium, DM) when myoblasts reached 80% con-
fluency. HEK293T cells (from ATCC) were maintained in
DMEM supplemented with 10% (v/v) fetal bovine serum.
For the analysis of protein stability of DAXX, 20 M of
MG132 was treated for 24 h. Transfection assays for RNAi
were carried out using Lipofectamine RNAimax (Invitro-
gen), according to the manufacturer’s instruction. C2C12
cells were transfected with siRNAs in myoblast states, and
differentiated into MT for the indicated times. siRNAs
against ChRO1 were designed using the The BLOCK-
iT™RNAi Designer, and synthesized by GenePharma. The
sequences of siRNAs are listed in Supplementary Table S1.
Antisense oligonucleotides (ASOs) against satellite repeat
RNA
Antisense oligonucleotides (ASOs) targeting major or mi-
nor satellite repeat RNAs were synthesized by the Cosmo
Genetech (Korea), as described in the previous report (21).
Sequences of ASOs are demonstrated in Supplementary Ta-
ble S1. One day after plating, C2C12 were transfected with
ASOs (0.1 M) using Lipofectamine 2000 (Invitrogen) and
then shifted to DM medium (0-day). Cells were further in-
cubated for 3 days before analysis.
RNA-FISH
For RNA-FISH, C2C12 were grown in 4-well culture slides
(Falcon), and in the case of MT, differentiated for 3–7
days. Cells were washed once in cold phosphate-buffered
saline (PBS), and fixed with 4% (w/v) formaldehyde and
10% acetic acid in PBS at RT for 10 min. After washing
with PBS twice, cells were permeabilized with 70% ethanol
by incubation at 4◦C for overnight. Cells were rehydrated
in 2× SSC (300 mM NaCl, 30 mM sodium citrate, pH
7.0) containing 50% formamide at RT, for 5 min. After
rehydration, cells were hybridized with 0.25 M of CAL
Fluor Red 610-labeled oligonucleotide probe set (Stellaris
Biosearch technologies), specific for ChRO1, in 2× SSC,
10% dextran sulfate, 2 mM vanadyl-ribonucleoside com-
plexes, 0.02% RNase-free bovine serum albumin, 40 g of
yeast tRNA and 50% formamide, for overnight at 37◦C. Af-
ter hybridization, slides were washed twice for 30 min at
37◦Cwith 2× SSC and 50% formamide. Nuclei were stained
with DAPI (20 g/ml, Invitrogen).
Rapid Amplification of cDNA Ends (RACE)
3′ RACE and 5′ RACE for identification of the exact loca-
tion of ChRO1a ends, were performed using 3′ or 5′ RACE
System for Rapid Amplification of cDNA Ends kit (Invit-
rogen). Primers for RACE are listed in the Supplementary
Table S1.
RNA extraction and RT-qPCR
RNA was purified by NucleoSpin® RNA (Macherey-
Nagel), according to the manufacturer’s instruction. Pu-
rified RNA (2 g) was used for cDNA synthesis with
cDNA synthesis kit (Thermo Fisher Scientific). RNA from
mice tissues was extracted from various tissues of four, 8-
week-old male C57BL6/J mice purchased from Daehan
BioLink (DBL). Quantitative polymerase chain reaction
(qPCR) was performed using the CFX96 system (Biorad)
and KAPA SYBR FAST Master Mix (KAPA Biosystem).
Relative quantification of PCR products was done by the
2CT (Livak) method. RNA level was normalized by
GAPDH unless otherwise mentioned in the figure legends.
The primers used for qRT-PCR are listed in the Supplemen-
tary Table S1.
Plasmid construction and stable cell lines
For synthesis of ChRO1a-cloned plasmid, PCR was per-
formed with cDNA synthesized from RNAs purified from
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MT using primers specific to ChRO1a as shown in Sup-
plementary Table S2. The PCR product was incorpo-
rated into TA vector (RBC). After confirmation of se-
quences, BamHI/EcoRI digested TA-ChRO1a was cloned
into pBabe-puro to establish the ChRO1a over-expressing
stable C2C12 cell line. Preparation of ChRO1 shRNA plas-
mids was performed as described previously (15) using
oligomers containing ChRO1-specific shRNA sequences
as listed in Supplementary Table S1. To generate ChRO1
shRNA stable cell line, lentiviral particles containing
ChRO1 shRNA was used to infect C2C12, followed by se-
lection with puromycin (2 g/ml, Biomax). H3.1 Flag-HA,
H3.3 Flag-HA or ChRO1a over-expressing stable C2C12
cell lines were also established in the same way that ChRO1
shRNA cell line was produced.
Myogenic conversion of NIH3T3
NIH3T3, mouse fibroblast was converted to muscle lin-
eage by expression of MyoD as previously described (22).
In detail, NIH3T3 fibroblasts were treated with retrovirus
containing pBabe puro MyoD. Thus infected NIH3T3
cells were selected with puromycin (2 g/ml, Biomax)
for 1 week. To induce muscle differentiation, media was
changed from GM to DM [DMEM containing 2% (v/v)
horse serum, 1× Insulin-Transferin-Selenium (ITS) supple-
ment (Sigma-Aldrich) and 2 g/ml puromycin (Biomax)]
for 3 days.
Deletion of the ChRO1 promoter using CRISPR/Cas9 sys-
tem
For ChRO1 knockout, a part of ChRO1 promoter was
deleted using CRISPR/Cas9 system. The pSpCas9(BB)-
2A-GFP(PX458) carrying wild-type Cas9 was from Ad-
dgene (#48138; http://www.addgene.org) (23). Two differ-
ent sgRNA oligos were designated using the CRISPR De-
sign Tool (http://crispr.mit.edu/). Cloning of sgRNAs into
pSpCas9(BB)-2A-GFP was performed as described previ-
ously (23). After sgRNA cloning into Cas9 containing plas-
mid, C2C12 or embryonic stem cell line (E14) were trans-
fected with 2 g of each sgRNA plasmid using lipofec-
tamine 2000 (Invitrogen), according to manufacturer’s in-
struction. GFP-positive cells were collected for sorting into
a 96-well cell culture plate with a BD cell sorter Aria™ (BD
Biosciences) followed by 24-h incubation. After 10 days, ge-
nomic DNA was extracted and amplified using a specific
primer set to confirm genomic knockout of the specific re-
gion. Primers used for sgRNAs and confirmation of ge-
nomic knockout are shown in Supplementary Table S1.
Muscle regeneration after cardiotoxin injury
Female C57BL/6J mice were purchased from Orient Bio.
To examine skeletal muscle regeneration, mice, blindly ran-
domized into groups, were anesthetized with a 1 - 2%
Isoflurane, followed by 50 l of 10 M cardiotoxin (CTX)
(Sigma-Aldrich) injection into the tibialis anterior (TA)
muscles. The TA muscles were harvested at 0, 2, 4, 7 and
14 days after injury. Total RNA prep, cDNA synthesis and
qPCR were performed as mentioned above. Primers are
listed in the Supplementary Table S1.
Self-renewal assay
Murine embryonic stem cells (E14) were trypsinized to sin-
gle cell suspension and plated on 0.1% gelatin-coated 6-
well culture plates. After 7 days, the culture medium was
aspirated and cells washed with PBS. Cells were fixed with
4% paraformaldehyde at room temperature for 2 min, fol-
lowed by rinsing with PBS twice. Cells were stained with
Fast Red Violet LB Salt (Sigma-Aldrich) and Naphthol A
S-BI-phosphate (Santa Cruz Biotechnology) at room tem-
perature for 15 min.
Nuclear fractionation
Nuclear fractionation was performed as described previ-
ously (24) with little modification for cytosol isolation. In
detail, cytosol was isolated by buffer A (100 mM HEPES-
KOH, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.05%
NP40, pH 7.9) with a protease inhibitor cocktail and cen-
trifuged at 3000 rpm, 4◦C, for 10min. Supernatant was kept
as ‘cytoplasmic fraction’. The steps for nuclear fractiona-
tion into nucleoplasm, and chromatin fraction were previ-
ously described (24).
Western blot analysis
Cells were washed twice with cold PBS and lysed by ly-
sis buffer (20 mM Tris–HCl pH 7.5, 1 mM ethylenedi-
aminetetraacetic acid, 150 mM NaCl, 0.5% NP-40) sup-
plemented with protease inhibitors and phosphatase in-
hibitors. Lysates were sonicated (Bioruptor) and cen-
trifuged (13 000 rpm, 4◦C) for 10min. Protein concentration
was determined and equal amounts of protein were sepa-
rated on sodium dodecyl sulphate-polyacrylamide gel elec-
trophoresis and transferred onto nitrocellulose membrane
before conventional western blotting experiments using pri-
mary antibodies listed in Supplementary Table S2.
Immunofluorescence and fusion index
Cells were fixed with 4% (w/v) paraformaldehyde, and per-
meabilized with 0.5% Triton X-100 in PBS. Cells were
blocked with 2% (w/v) bovine serum albumin in PBS, and
incubated with the primary antibodies shown in Supple-
mentary Table S2. Alexa 594-conjugated anti rabbit goat
IgG and Alexa 488-conjugated anti mouse goat IgG (Invit-
rogen) were used as secondary antibodies. DNA in the nu-
clei was detected by DAPI staining (20 g/ml, Molecular
Probes). Immunofluorescence was examined using an LSM
700Confocalmicroscopy (Carl Zeiss), and images were pro-
cessed by ZEN software for calculation of the correlation
coefficient R between DAPI and red signals. The number of
chromocenters was manually counted by ImageJ with im-
ages that were taken by Z-stack. For analysis of percentage
ofmyosin heavy chain (MyHC)-positive cells, the number of
nuclei co-stainedwithMyHCwas counted in at least 10 ran-
dom microscopic fields. The percentage of MyHC-positive
cells was calculated by dividing the number of MyHC pos-
itive nuclei by the total nuclei. Fusion index was calculated
by the ratio of nuclei that appear as more than two in one
cell to the total number of nuclei.
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Chromatin immunoprecipitation (ChIP)
C2C12 cells were cross-linked with 1% formaldehyde at
RT for 10 min. Crosslinking was quenched by incubation
in 0.125 M glycine for 5 min at RT. After three washing
steps on ice with PBS, cells were lysed and sonicated for
45 min at 0◦C to produce DNA fragments ranging be-
tween 200 and 1000 bp (Bioruptor). After centrifugation,
2% of lysate was de-crosslinked for 4 h at 65◦C followed
by RNaseA treatment for 1 h at 50◦C. Agarose gel elec-
trophoresis to confirm the size range of DNA fragments
and quantification was performed with the de-crosslinked
DNA. Antibodies and beads were added to the 25 g of
chromatin samples and incubated overnight at 4◦C with ro-
tation. After washing serially with low salt, high salt, LiCl
buffer and TE buffer, immunoprecipitated chromatin was
de-crosslinked for 4 h at 65◦C followed by RNaseA treat-
ment, and then DNA was purified using PCR purification
kit (QIAGEN). We performed ChIP-qPCR using primers
targeting peri/centromere in MT (25). The relative amount
of immunoprecipitated DNAwas calculated as the percent-
age of input DNA. Primers used for ChIP are listed in the
Supplementary Table S1.
Formaldehyde-Associated Isolation of Regulatory Elements
(FAIRE) assay
Formaldehyde-Associated Isolation of Regulatory Ele-
ments (FAIRE) assay was performed as described previ-
ously (26), with modification. In detail, cells were cross-
linkedwith 1% formaldehyde for 5min at RT, and quenched
by incubation with 0.125 M glycine for 5 min at RT with
shaking. After three washes with PBS, cells were lysed and
sonicated for 30 min at 0◦C (Bioruptor). After centrifu-
gation, 10% input from supernatant was taken and de-
crosslinked with RNaseA and proteinase K. DNA from the
remaining cell lysate was purified by phenol–chloroform–
isoamylalcohol extraction before de-crosslinking. DNA
was then de-crosslinkedwithRNase and proteinaseK treat-
ment at 65◦C overnight. Final purification was done after
overnight de-crosslink, and FAIRE enrichment was ana-
lyzed by qPCR using primers targeting major satellite and
minor satellite repeats. See the Supplementary Table S1 for
primers.
Detection of CpG methylation at pericentromere
CpG methylation of pericentromere in C2C12 was ana-
lyzed by digestion of genomic DNA with HpyCH4IV, fol-
lowed by qPCR with primers targeting pericentromeric re-
gion as shown in Supplementary Table S1 (19). Genomic
DNA from C2C12 was extracted by phenol, and puri-
fied by ethanol precipitation. Equal volume of genomic
DNAs (5 g) were digested with 10 units of HpyCH4IV for
overnight, leaving 0.1 g of genomic DNA without diges-
tion, for input. Enzyme-digested genomic DNA was puri-
fied, and analyzed with two primer sets: targeting digestion-
free region (without ACGT) and ACGT containing region.
Relative HpyCH4IV was determined by comparison be-
tween% input of PCRproducts of digestion-free region and
the ACGT containing region.
RNA pull-down, chromatin isolation by RNA purification
(ChIRP) and RNA immunoprecipitation (RNA-IP)
RNA pull-down and chromatin isolation by RNA purifi-
cation (ChIRP) using biotinylated antisense (AS) oligonu-
cleotides against ChRO1 were performed as previously de-
scribed (27,28) with modifications. 5′ biotinylated AS nu-
cleotides (20-mers) targeting ChRO1 or LacZ for negative
control were synthesized by Integrated DNA Technologies,
of which sequences shown in the Supplementary Table S1.
RNA purification after pull-down was performed by us-
ingNucleoSpin® RNA (Macherey-Nagel) according to the
clean-up protocol of manufacturer’s instruction. The rel-
ative amount of enriched RNA was demonstrated as the
percentage of input RNA. For the calculation of relative
enrichment, normalization by the percentage input of AS-
LacZ was carried out. For ChIRP, DNA purification was
performed after pull-down using PCR purification kit (QI-
AGEN). Quantitative PCRusing primers targeting pericen-
tromere and centromere was carried out. ChRO1 enriched
DNA was represented as the relative enrichment, with nor-
malization by the % input of AS-LacZ. RNA-IP was per-
formed using indicated antibodies as previously described
with modifications (29). After immunoprecipitation, equal
volumes of purifiedRNAswere used for cDNA synthesis by
cDNA synthesis kit (Thermo), and qPCR was performed.
The relative amount of immunoprecipitated RNA was rep-
resented as the percentage of input RNA, and then finally
relative enrichment was obtained from division by Flag-,
HA-, or IgG-immunoprecipitated ChRO1. Supplementary
Table S1 lists the primers used for RNA-pull down, ChIRP,
and RNA-IP.
Conserved domain search
To identify conserved regions, we aligned transcribed se-
quences of human ChRO1 against mouse ChRO1. We took
the sliding-window approaches. For the first approach, we
made a 200 nt-long window on each human RNA sequence
and shifted the window by 40 nt to align against the whole
length of the transcribed mouse RNA sequence. We used
MATLAB function localalign, which returns local opti-
mal and suboptimal alignments between two sequences. We
found highly concordant search results and further ana-
lyzed the alignments by applying the following steps: (i) re-
tain alignments only if the alignment score is>20 or the ra-
tio of identicalmatches is>80%, (ii) remove duplicate align-
ments among isoforms of RNAs based on merged isoforms
of RNA list, (iii) remove alignments if the aligned regions
in human and mouse RNAs are not in same order of exons
on their transcribed sequences and (iv) retain the best align-
ment if there are multiple alignments for the same region.
Motif search in conserved regions
To determine which regulatory motifs are over-represented
in conserved regions with respect to background non-
conserved regions, we identified all possible ungapped 8-
mers in conserved domains and computed their frequency.
In the list of motifs, we found the presence of repeats that
are consisted of a single nucleotide or dimer repeated for
the entire 8-mer. This phenomenon is common in genomic
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sequences and generally is associated with non-functional
components, and thus, these were filtered out. To assess the
statistical significance of the computed frequency for the
over-represented motifs, we generated random sequences
according to the nucleotide composition of the original sets
of sequences. The frequencies for the random 8-mers were
computed, and the distribution of the frequencies was ap-
proximated by the extreme value distribution. We used the
MATLAB function gevfit to compute the maximum like-
lihood estimation of the extreme value distribution. We
then overlaid a scaled version of its probability density
function, computed using MATLAB function gevpdf, with
the histogram of the frequency of the random 8-mer se-
quences. We repeated this process 100 times for bootstrap-
ping and calculated the P-value. We concluded that the
over-representation of the 8-mer motifs in conserved do-
main is statistically significant if the P-value estimate is
<1.0E-4.
Consensus motifs and de novo motif discovery
To identify consensus motifs, 47 enriched 8-mers were phy-
logenetically clustered into 10 groups. We used the MAT-
LAB function seqlinkage to construct phylogenetic tree
from pairwise distances. We then used the MATLAB func-
tion seqlogo to identify consensus motifs and their weight
matrix for the clustered 8-mer(s) in each group. We found
known transcription factors per 10 identified consensus that
have aligned part of sequence with the consensus by using
the MEME suite.
Hi-C topological associated domains and loops
We used the JuiceBox (http://www.aidenlab.org/juicebox/)
(30) to visualize Hi-C topological associated domains and
loops. TheHi-CGM12878 cell data downloaded fromGEO
(GSE63525).
Statistical analysis
All experiments were performed at least three times inde-
pendently under similar conditions, unless otherwise spec-
ified in the figure. Results were demonstrated as mean val-
ues with error bars representing standard errors of means.
Statistical analysis was carried out using GraphPad Prism
v7.0 (GraphPad Software) and Microsoft Excel 2007 (Mi-
crosoft) to assess the differences between experimental
groups. Statistical significance between two groups was an-
alyzed by unpaired, two-tailed Student’s t-test. One-way
analysis of variance (ANOVA) was performed for compar-
ison of multiple groups. F-values and Degree of Freedom
were stated in the figure legend where ANOVAwas used for
determination of statistical significance.P < 0.05 were con-
sidered to be statistically significant. Determined P-values
were indicated in the figures.
Ethical compliance
All animal experiments were approved by the Institu-
tional Animal Care and Research Advisory Committee at
Sungkyunkwan University School of Medicine Laboratory
Animal Research Center.
Detailed methods about microarray analysis and RNA-
seq analysis are provided in the supplementary file.
RESULTS
ChRO1 is a lncRNA expressed in terminally differentiated
muscle cells
To search for novel lncRNAs that function as myogenic
regulators, we performed RNA-seq with poly(A)-selected
RNAs from proliferating C2C12 myoblasts and cells that
had been differentiated into either MT or osteoblasts (Sup-
plementary Figure S1A–E). Among differentially expressed
genes, 194 ncRNAs, significantly upregulated during myo-
genesis, were further explored. We ranked the top 40
most highly induced lncRNAs, and individually analyzed
them by filtering with features of H3K4-H3K36 methyla-
tion and a loss-of-function analysis using siRNAs (Sup-
plementary Figure S1F and G). These efforts led us to
discover a previously unannotated lncRNA, hereinafter
termed ChRO1 (Chromatin reorganization 1). ChRO1 was
located at chr 7, and highly expressed inMT, but not in my-
oblasts or osteoblasts. The promoter region of ChRO1 gene
was enriched by pol II and myogenic regulatory factors,
MyoD andMyogenin, in a cell-type specificmanner (Figure
1A). ChRO1 was produced as two isoforms, ChRO1a and
ChRO1b. We cloned ChRO1a using the rapid amplification
of complementary DNA ends (RACE), which yielded an
unspliced 1337 nt transcript with a genomically encoded
poly (A) site. ChRO1b was estimated as an ∼11 000 nt
transcript. Both ChRO1a and b were induced as robustly
as other well-known myogenic lncRNAs during muscle dif-
ferentiation (Figure 1B) (31–35). As expected, quantitative
RT-qPCR using primer pairs that span the ChRO1 locus
(Figure 1C) and the ChIP assay using pol II antibody (Fig-
ure 1D) showed that ChRO1 was transcribed by pol II and
dramatically induced during myoblast differentiation.
To ascertain whether ChRO1 is a bona fide muscle-
specific lncRNA, we showed that when NIH3T3 fibrob-
last cells were acutely converted into the muscle lineage by
MyoD, ChRO1 was strongly induced (Figure 1E). Further-
more, ChRO1 was highly enriched in cardiac and skele-
tal muscle of adult mouse (Figure 1F), and its level was
promptly induced after injury followed by the recovery pro-
file of MyHC during muscle regeneration (Figure 1G). In
added support, analysis of public data sets of RNA-seq
from various cells indicated that ChRO1 expression was
highly specific to muscle (Supplementary Figure S2A).
Intriguingly, comparative analysis identified a syntenic
human ortholog located on chr 19, whose expression profile
also showed preferential enrichment in muscle cells (Figure
1H).Notably,mouse and humanChRO1 exhibited a signifi-
cant level of sequence conservation (local alignment score>
20 or ratio of direct alignment per nucleotide>80%) (Figure
1I). Further searching for repeat elements revealed a ‘CTC-
CTC’ motif (Monte Carlo P-value 6.37E-06), and related
phylogenic variants that are often recognized by various
zinc finger proteins (Supplementary Figure S2B). ChRO1
might be one of the tapRNAs that were recently charac-
terized (36), as it is situated at the borders of topologically
associating domains (TADs) (Supplementary Figure S2C).
Collectively, our data show that ChRO1 is a muscle-specific
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Figure 1. ChRO1 is a muscle-specific lncRNA induced during myogenesis (A) Schematic representation of the ChRO1 genomic locus. Occupancies of
myogenic transcription factors are shown. MB, myoblasts; MT, myotubes; OB, osteoblasts; Pol II, RNA polymerase II; Pol II-S2, Serine 2 phosphorylated
RNA polymerase II. (B) Fold changes of lncRNA levels during myogenesis were calculated from FPKM. (C) ChRO1 RNA was measured by RT-qPCR
under growth (myoblasts, MB) or differentiation condition (Day 1, 2, 3) using amplicon primers as shown in (A). (D) Occupancy of pol II (8WG16) on
the 0.6K and 1.3K upstream regions from the ChRO1 transcription start site in MB and MT, differentiated for 3 days (D3). (E) RT-qPCR for MyoD,
Myogenin and ChRO1 in myogenesis-induced NIH3T3. (F) RT-qPCR for ChRO1 in various mouse tissues. RNA level was normalized by 18S rRNA. n
= 4 biological replicates, one-way ANOVA, P < 0.0001, Degree of Freedom = 6, F-value = 15.83. (G) RT-qPCR of ChRO1 and MyHC during muscle
regeneration after injection of CTX into TA muscle of mice. RNA level was normalized by 18S rRNA, n = 4. One-way ANOVA, P < 0.0001, Degree of
Freedom = 4, F-value = 64.12 for ChRO1 and 107.7 for MyHC. (H) Expression of ChRO1 in human cells. GRCh27/hg19 was used as a human genome
reference. (I) Conserved regions identified by sliding-window local alignment are shown at bottom. Identical sequence alignments (conserved domains)
between human and mouse ChRO1 are represented in red.
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lncRNAwith highly conserved regions between human and
mouse, whose expression is upregulated upon myoblast dif-
ferentiation.
ChRO1 is localized at chromocenters, and associated with
myotube-specific heterochromatin compartmentalization
Biochemical fractionation of MT revealed that ChRO1 lo-
calized in the nucleus (Supplementary Figure S3A) and
stably associated with chromatin (Supplementary Figure
S3B). To further characterize, we performed RNA-FISH
with fluorescence-labeled oligonucleotide probes recogniz-
ing ChRO1. This effort confirmed that ChRO1was detected
only in the nuclei of MT, while it disappeared following
RNase treatment (Figure 2A). Furthermore, surprisingly,
ChRO1 typically appeared as 5–20 large bright foci in the
nucleus that co-localized withDAPI-dense foci (Figure 2B).
As DAPI foci represent pericentromeric heterochromatin
(PCH), the major constituents of constitutive heterochro-
matin compartments in mouse (37), our data indicated that
ChRO1 preferentially localized at PCH domains in MT nu-
clei. To confirm the focal localization of ChRO1 at PCH,
we performed an RNA pull-down assay using ChRO1-
specific and LacZ-specific AS oligonucleotides as a control.
RT-qPCR analysis showed that ChRO1 was specifically
pulled down by AS-ChRO1 with co-precipitation of peri-
centromeric and centromeric repeat-derived RNAs, MajS
and MinS (Figure 2C). This interaction was specific, as
U2 snRNA was not coprecipitated. It also coprecipitated
peri/centromeric repeat DNAs, demonstrating that ChRO1
was associated with the peri/centromeric chromocenters
(Figure 2D).
During myogenesis, chromocenters consist of PCH do-
mains fused together to form chromocenter clusters, which
are easily recognized by an increase in size and reduction
of the number of DAPI foci (19,20). Because ChRO1 was
localized at the chromocenters, we were particularly in-
terested in exploring whether ChRO1 might be involved
in the reorganization of PCH domains during myogene-
sis. To test this, we used two independent ChRO1-specific
siRNAs: siChRO1-1, designed to target both isoforms, and
siChRO1-2 specific for ChRO1b. C2C12 cells were treated
with siRNAs and allowed to differentiate for 3 days. ChRO1
was efficiently downregulated by both siRNAs (Figure 2E).
Strikingly, our data showed that DAPI foci appeared scat-
tered and diffusely distributed upon ChRO1 knockdown
with an increase of the number of DAPI foci, implying
that chromocenter clustering was impaired with the abla-
tion of ChRO1 (Figure 2F). Altogether, our data suggest
that ChRO1 resides in MT chromocenters and might have
a role in chromocenter clustering.
ChRO1 affects myogenesis
We next explored the role of ChRO1 in myogenic differ-
entiation by modulation of its expression through RNAi
or ChRO1a overexpression. C2C12 myoblasts were treated
withChRO1 siRNAs and shifted to differentiationmedium.
Differentiation status was monitored by the expression of
muscle markers. When ChRO1 was depleted, both protein
and mRNA levels of myogenic markers (MyHC, MCK
and Troponin T) were significantly decreased in MT dif-
ferentiated for 3 days, compared to siRNA control (Figure
3A and B). In addition, immunostaining data confirmed
that MyHC+ population and the multi-nucleated cell fu-
sion index were obviously reduced by ChRO1 knockdown
(Figure 3C). We also established C2C12 clones stably ex-
pressing ChRO1-specific shRNA. Although these cells had
no growth defect for myoblast proliferation (Supplemen-
tary Figure S4A), they showed significant impairment of
chromocenter clustering (Supplementary Figure S4B) and
marked reduction in MyHC, MCK, Myogenin and Tro-
ponin T levels, when shifted to differentiationmedium (Fig-
ure 3D and E). In addition, the effect of ectopic expression
of ChRO1 was determined by expression of ChRO1a that
carries a part of the conserved sequences. RT-qPCR analy-
sis demonstrated that ChRO1a was indeed efficiently over-
expressed in C2C12 cells throughout differentiation (Fig-
ure 3F). Overexpression of ChRO1a led to high levels of
muscle markers (Figure 3G) and increased population of
MyHC+ cells (Figure 3H). Furthermore, it induced chro-
mocenter clustering, even in growth state (Supplementary
Figure S4C), and led to the accelerated expression ofMyHC
and Troponin T, when cells were grown to high cell density
(Supplementary Figure S4D).
Many lncRNAs function as cis-acting regulators of their
neighboring genes (38). We therefore tested whether this
might be true of ChRO1 as a mode of action. Analysis of
genes located within 100 kb from the ChRO1 site showed
that their expression was hardly affected by ChRO1 deple-
tion (SupplementaryFigure S5A), suggesting the possibility
that ChRO1 might act in trans. We also established ChRO1
knockout by deleting the promoter proximal MyoD bind-
ing sites using the CRISPR/Cas9 system in a background
of C2C12 or ES cells (Supplementary Figure S5B). These
results consistently showed that myogenic differentiation
was greatly affected by ChRO1 knockout (Supplementary
Figure S5C and D), whereas trans-differentiation into os-
teoblasts (Supplementary Figure S5E) or the pluripotency
and differentiation potential of ES cells (Supplementary
Figure S5F–I) were completely normal. Our data suggest
that ChRO1 is required for the terminal differentiation of
myoblasts in a lineage-specific manner.
In an attempt to gain more insight on a global scale,
we performed microarray analysis to compare control and
shChRO1 cells at bothmyoblast andMT states.Many genes
differentially regulated during myogenesis (MT/MB) were
greatly affected by ChRO1 knockdown (Figure 3I). A to-
tal of 635 genes were identified as either up- or downregu-
lated by ChRO1 knockdown. GO analysis further revealed
that many affected genes included a large portion of genes
involved in muscle development and its regulation (Figure
3J). In addition, the motif analysis to predict transcription
factors associated with the affected genes (MSigDB v6.0),
revealed important myogenic regulators such as MyoD,
Mef2a and E12/E47 (Supplementary Figure S5J). Taken
together, our results demonstrate that ChRO1 functions as
a positive regulator of muscle differentiation, with a broad
impact on myogenic gene expression.
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Figure 2. ChRO1 is enriched at chromocenters and associated with heterochromatin reorganization (A) RNA-FISH for ChRO1 in MT (Day 7). RNase
A was either treated or not. Scale bars, 50 m. (B) Representative MT nuclei of RNA-FISH analysis. (C) Experimental scheme of RNA pull-down for
analysis of ChRO1-interacting DNA/RNA by using biotinylated ChRO1-AS oligonucleotides (AS-ChRO1) (left). RT-qPCR of ChRO1, MajS, MinS and
U2 RNAs after RNA pull-down (right). AS-LacZ (AS oligonucleotides targeting LacZ) was used for a negative control. (D) DNA was analyzed by qPCR
with primers for pericentromere (PeriCEN) and centromere (CEN) after ChIRP. (E) RT-qPCR of ChRO1 with amplicons to confirm ChRO1 knockdown
using two specific siRNAs. (F) DAPI-staining of ChRO1-depleted MT (left). Number of chromocenters per MT nuclei is shown (right).
ChRO1 is involved in heterochromatin compaction through
relocalization of chromatin factors to chromocenters
As ChRO1 resides predominantly at PCH chromocenters
in MT, we next asked whether ChRO1 could affect chro-
matin compaction. To do this, nucleosome-free MajS and
MinS repeats were analyzed by FAIRE assay (26,39). These
regions changed into more condensed chromatin state
with differentiation (Supplementary Figure S6A). However,
ChRO1 knockdown resulted in decondensation, while its
over-expression caused further compaction of chromatin
in myoblasts and D1 MT (Supplementary Figure S6B–D).
Consistently, CpG methylation of pericentromere was af-
fected by ChRO1 (Supplementary Figure S6E–G), demon-
strating that ChRO1 was involved in DNAmethylation and
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Figure 3. Muscle differentiation is impaired by ChRO1 depletion. (A) Western blot for MyHC and Troponin T in 3-day differentiated MT after siRNA
treatment. -tubulin was used as a loading control. (B) RT-qPCR forMyHC and muscle creatin kinase (MCK) in siRNA-treated C2C12 that was differen-
tiated for 3 days. (C) Representative immunofluorescence for MyHC and DAPI staining. Scale bars, 50 m (left). MyHC-positive cells and fusion index in
MT (right). (D) Western blots for MyHC, Troponin T and Myogenin in either shCtrl or shChRO1 MB and MT (Day 3). Lamin B1 was used as a loading
control. *: non-specific band, arrow indicates Myogenin. (E) RT-qPCR for ChRO1, MyHC, MCK and Myogenin in shCtrl or shChRO1 MT (Day 3). (F)
RT-qPCR of ChRO1a in empty or ChRO1a over-expressing C2C12 cells in growing (MB) or differentiation (Day 1, Day 2) medium. n = 4 independent
experiments. (G) Western blots for MyHC and Troponin T with ChRO1a over-expressing MB and MT (Day 1, Day 2). -tubulin was used as a loading
control. (H) MyHC immunostaining of 1 day-differentiated C2C12 cells over-expressing ChRO1a. Scale bars, 50m. (I) Differentially expressed genes of
shCtrl or shChRO1 C2C12 (Fold Change > 2, P < 0.05). Data are shown as log 10 of fold change. (J) Gene ontology analysis of ChRO1-depleted cells,
shown in log P-value.
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heterochromatin compaction at peri/centromeric domains
during muscle differentiation.
Based on the data above and its requirement for
differentiation-associated chromocenter clustering, we hy-
pothesized that ChRO1 might display a pro-myogenic
function by facilitating constitutive heterochromatin re-
organization. Accordingly, we first sought any chromatin
signatures that parallel the myogenic progress, particu-
larly focusing on the histone marks related to heterochro-
matin function. The global levels of histone methylation
of H3K4, H3K9 or H3K27 were not significantly changed
during myoblast differentiation, however H4K20me3 was
prominently induced, while H4K20me1 and H4K20me2
were decreased (Figure 4A). Furthermore, in contrast
with Suv39H1 or Ezh2 that declined with myogenesis,
as reported previously (40,41), Suv420H2 was maintained
throughout myogenic differentiation (Figure 4B), imply-
ing that differentiation-associated chromocenter clustering
might be accompanied by gain of H4K20me3 mediated
by Suv420H2. Next, we examined the effect of ChRO1 on
the levels of histone methylation and HMTs. Surprisingly,
neither histone methylation nor HMTs were significantly
affected by ChRO1 knockdown (Figure 4C), which sug-
gested that the pro-myogenic activity of ChRO1 might not
be necessarily related to the control of the total amount of
H4K20me3 or Suv420H2.
Since the global level of histone modifications was not
changed by ChRO1, we speculated that ChRO1 would be
necessary for proper localization of histone marks or chro-
matin factors in the nuclear compartment. In order to ex-
amine this, we initially tested the relative distribution of re-
pressive histone marks and heterochromatin factors upon
differentiation, by immunofluorescence. The correlation co-
efficient R was applied to quantitatively determine the spa-
tial colocalization of each target with DAPI foci. Consis-
tent with previous reports (42), the focal enrichment of
H3K9me3 and HP1 to chromocenter clusters was mod-
estly but significantly increased in MTs (Supplementary
Figure S7A and B). Whereas, H4K20me3, Suv420H2 and
Smc3 (cohesin subunit) were robustly enriched at chromo-
centers in MTs (Supplementary Figure S7C–E), which was
also revealed by ChIP assay (Supplementary Figure S7F
and G). Our data suggest that global relocalization of het-
erochromatin factors occurred with clustering of chromo-
centers in MTs.
These results prompted us to test whether ChRO1 might
be required for the enrichment of H4K20me3 and other
chromatin factors at chromocenters in MTs. Strikingly,
C2C12 cells with ChRO1 knockdown exhibited complete
mislocalization of H4K20me3 from chromocenters to nu-
cleoplasm (Figure 4D), which was again confirmed by ChIP
assay (Supplementary Figure S7H and I). Consistently,
chromocenter localization of Suv420H2 was significantly
affected by ChRO1 depletion (Figure 4E), although local-
ization of H3K9me3 was largely unchanged (Figure 4F). In
addition, ChRO1 knockdown resulted in nuclear diffusion
of Smc3 from chromocenter foci without affecting protein
levels (Figure 4G and Supplementary Figure S7J). Like-
wise, relocalization of HP1 andMeCP2 to chromocenters
was modestly but significantly impaired by ChRO1 knock-
down (Figure 4H and I). Therefore, our data suggest that
ChRO1 plays an important role in chromocenter loading of
heterochromatin-associated factors, especially for the steps
downstream of Suv39H/H3K9me3.
ChRO1 regulates satellite RNAs through ATRX/DAXX-
dependent deposition of H3.3
In order to further investigate the mechanism we assessed
the MajS and MinS repeat RNAs that were reported to
be induced during myogenesis (43). Both RNA transcripts
were indeed strongly induced in MTs (Figure 5A). How-
ever, they were significantly reduced by ChRO1 knock-
down, while were increased by ChRO1a over-expression
(Figure 5B and Supplementary Figure S8A), implying a po-
tential link between ChRO1 and local ncRNAs.
Pol II and ATRX/DAXX-dependent deposition of H3.3
are known to be necessary for the initial synthesis of satel-
lite RNAs (13,44). Therefore we examined by ChIP whether
the occupancy of pol II and H3.3 at peri/centromeric re-
gions was affected by ChRO1. Pol II and H3.3 normally
increase at these regions with differentiation (Supplemen-
tary Figure S8B and C), but were significantly reduced by
ChRO1 knockdown (Figure 5C andD), demonstrating that
the satellite RNA transcription by pol II and H3.3 incor-
poration were dependent on ChRO1. Next, we examined
whether ChRO1 could play a role in ATRX/DAXX/H3.3-
mediated H3.3 deposition at chromocenters. To this end,
we performed RIP using C2C12 cells stably expressing
the epitope-tagged H3.1 or H3.3 (Flag/HA). Despite both
H3.1 and H3.3 being immunoprecipitated with similar ef-
ficiency, in striking contrast, ChRO1 was co-precipitated
with H3.3 (Figure 5E). This variant-specificity was further
confirmed by RIP with endogenous proteins, showing that
ChRO1 specifically interacted with ATRX/DAXX/H3.3,
but not with HIRA/H3.3 (Figure 5F–I). We analyzed the
interaction domain and found that the N-terminal domain
of DAXX was involved in ChRO1 binding (Supplementary
Figure S8D).
Salsman et al. reported that DAXX switches its posi-
tion from the PML nuclear bodies to the PCH compart-
ment during myogenesis (45). Consistently, we also ob-
served the significant induction of chromocenter localiza-
tion with DAXX during myogenesis (Supplementary Fig-
ure S8E), whereas ATRX was associated with chromocen-
ters both in MB and MT without changing its position
(Supplementary Figure S8F). These suggest that reposition-
ing of DAXX to chromocenters is likely to be regulated by
ChRO1. Indeed, recruitment of DAXX to chromocenters
was significantly affected by ChRO1 knockdown (Figure
5J). TheDAXXprotein level, but notmRNA level, was also
partially affected (Supplementary Figure S8G–I). However,
interestingly, ATRX comparatively remained co-localized
with DAPI foci with reduction of correlation R, upon
ChRO1 knockdown, indicating that ATRX remained asso-
ciated with PCH even when chromocenter clustering was
impeded (Figure 5K). These data suggest that ATRX may
be involved in ChRO1/DAXX/H3.3 complex loading as a
binding platform. Indeed, as expected, siRNA knockdown
ofATRX resulted in redistribution ofDAXX from chromo-
centers and mislocalization of ChRO1 as a dispersed pat-
tern (Figure 5L andM), implying that ATRXmay function
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Figure 4. ChRO1 is responsible for heterochromatin compaction via facilitating localization of chromatin factors to chromocenters. (A) Western blots
for various histone modifications in MB and MT (Day 1–3). (B) Western blots for Suv420H2, Suv39H1, Ezh2, MyHC and Troponin T in MB and MT
(Day 1–3). (C) Western blots for histone modifications and HMTs in ChRO1-depleted MT (Day 3). H4 and Lamin B1 are the loading controls. (D–I)
Representative MT nuclei of immunostaining (left) and correlation R (right) are shown for H4K20me3, Suv420H2, Smc3, H3K9me3, HP1 and MeCP2,
respectively, in ChRO1-depleted or control MT.
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Figure 5. ChRO1 mediates satellite RNA accumulation through ATRX/DAXX/H3.3 localization at peri/centromeric chromocenters. (A) RT-qPCR for
MajS and MinS RNA transcripts in MB and MT (Day 1–Day 3). (B) RT-qPCR for MajS and MinS in siRNA-treated C2C12. (C) ChIP-qPCR demon-
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as a major determinant for placing ChRO1/DAXX/H3.3
at these particular genomic loci.
Next, we investigated whether focal enrichment of
ChRO1/ATRX/DAXX and H3.3 incorporation directly
affect the chromocenter reorganization andmuscle differen-
tiation. Indeed, siRNA knockdown of ATRX orDAXX re-
sulted in defective chromocenter clustering and poor myo-
genic differentiation (Figure 5N andO; Supplementary Fig-
ure S9A–D). Furthermore, direct targeting of H3.3 by the
mixture of siRNAs that deplete both H3f3a and H3f3b led
to reduced chromocenter clustering and defective cell dif-
ferentiation (Figure 5P; Supplementary Figure S9E and F).
In addition, knockdown of ATRX, DAXX and H3.3 all re-
sulted in reduced satellite RNA levels (Supplementary Fig-
ure S9G–I). Combined, these data support the idea that
ChRO1 cooperates with ATRX to localize DAXX/H3.3 to
chromocenters, which is important for H3.3 incorporation,
satellite RNA transcription and higher-order heterochro-
matin reorganization.
Satellite repeat RNAs are involved in large-scale reorganiza-
tion of constitutive heterochromatin during myogenesis
As satellite repeat RNAs were elevated via ChRO1-
mediated enrichment of ATRX/DAXX/H3.3 at chromo-
centers, we tried to investigate whether these local ncR-
NAs perform a function for chromocenter clustering dur-
ing myogenesis. To address this, we attempted to de-
plete MajS and MinS RNAs using antisense RNA/DNA
oligonucleotides (ASO), which promote degradation of tar-
get RNAs via endogenous RNase H (Figure 6A). C2C12
cells were treated withMajS orMinS-ASOs when cells were
induced for differentiation and incubated for 3 days be-
fore analysis. Both MajS and MinS were downregulated by
ASO treatment with an efficiency of 40–50%, while the level
of ChRO1 remained unaffected (Figure 6B). Interestingly,
knockdown of MajS andMinS repeat RNAs led to marked
increase of the number of chromocenters compared to
mock control (Figure 6C). Concomitant with this, mRNA
levels of MyHC and MCK were significantly reduced in
ASO-treated MT (Figure 6D), indicating that muscle dif-
ferentiation as well as chromocenter clustering was signif-
icantly affected upon satellite RNA knockdown. Next, we
investigated whether MajS and MinS RNAs were required
for ChRO1 localization at chromocenters. The RNA-FISH
data for ChRO1 in MajS- or MinS-ASO-treated MTs show
that ChRO1 remained stably associated with chromocen-
ters, albeit fallen apart (Figure 6E), indicating that satel-
lite RNAs were dispensable for ChRO1 localization. These
results suggest that ChRO1/ATRX/DAXX/H3.3 recruit-
ment proceeds satellite transcription, and these local RNAs
are critical players in heterochromatin reorganization and
muscle differentiation.
DISCUSSION
In this study, we report the identification and compre-
hensive characterization of previously unknown lncRNA
ChRO1, which is highly expressed in terminally differ-
entiated muscle cells and specifically localized in the
differentiation-associated heterochromatic nuclear com-
partments. Upon differentiation, ChRO1 recruits and sta-
bilizes the ATRX/DAXX/H3.3 complex at chromocen-
ters, which is responsible for H3.3 incorporation for pol
II-mediated transcription of satellite RNAs and clustering
of chromocenters (Figure 6F). This PCH/CH-based chro-
matin reorganization is necessary for appropriate execution
of gene expression for progression into the terminal myo-
genic differentiation path. Our current model also points to
satellite RNAs as essential components for chromocenter
clustering and myogenesis. In comparison with other scaf-
fold RNAs (46,47), ChRO1 is unique, as it does so, in part,
through transcriptional induction of satellite repeats with
the binding capacity toward H3.3-specific histone chaper-
one.
ATRX/DAXX is proposed to play a role in genomic
stability through regulation of repetitive regions such as
telomeres and pericentromeres (48–50), where the ADD
(ATRX-DNMT3-DNMT3L) domain of ATRX is impli-
cated in H3K9me3/H3K4me0 binding to recruit this com-
plex to appropriately marked genomic loci (51,52). ATRX
also interacts with HP1 via domain adjacent to ADD,
these domains all provide ATRX the ability to instruct
where H3.3 should be incorporated along the genome.
Whereas, DAXX has SIM (SUMO-interacting motif) do-
mains responsible for DAXX/H3.3 association with PML
nuclear bodies via SUMO-mediated interaction (53). Al-
though ATRX/DAXX-dependent H3.3 deposition path-
way is suggested to operate from PML bodies to H3K9me3
marked genomic regions, the details of molecular interplay
and dynamics are still not known (45,54). Nonetheless the
fact that ATRX and DAXX/H3.3 emerge on chromocen-
ter clusters during myogenesis implies that heterochromatin
reorganization is a high priority of muscle cells for the cell
differentiation. In this regard, ChRO1 serves as a regula-
tory RNA for the relocalization of DAXX/H3.3 and stable
formation of ATRX/DAXX/H3.3 complex at chromocen-
ters in myogenic cells. Our interaction domain analysis fur-
ther revealed that the ChRO1–DAXX interaction involves
N-terminal ∼180 residues of DAXX that include the SIM
and the ATRX-interacting DHB (DAXX helical bundle)
domains, which suggest that sumoylation could be an ad-
ditional component of dynamic relocalization.
Satellite repeat RNAs function exclusively in cis for
the establishment of heterochromatin structure (55,56).
In fission yeast, these RNAs are amplified by Dicer and
RNA-dependent RNA polymerase, guide Clr4/Suv39H
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
strating pol II occupancy at peri/centromeres in ChRO1-depleted MTs (Day 3). (D) ChIP-qPCR for H3.3 occupancy at indicated genomic regions in
ChRO1-depleted MTs (Day 3). (E) Western blots for IP of Flag/HA tagged H3s using antibodies against Flag or HA (left panel). Detection of ChRO1 by
RT-qPCR following H3 IP (right panel). (F–I) RT-qPCR for ChRO1 after IP of endogenous H3.3, DAXX, ATRX or HIRA in MTs (Day 3). IP/Input
of ChRO1 was normalized by the value of IgG. Pre-rRNA or GAPDH was used as a negative control. (J and K) Representative immunofluorescence and
correlation R for DAXX and ATRX in ChRO1-depleted MTs (Day 3). (L) Representative immunofluorescence and correlation R for DAXX in ATRX-
depleted MTs (Day 3). (M) RNA-FISH for ChRO1 in ATRX-depleted MTs (Day 3). Correlation R for ChRO1 in ATRX-depleted MTs is shown. (N–P)
DAPI staining for ATRX-, DAXX- or H3.3-depleted MTs (Day 3). The number of chromocenters per nucleus is demonstrated.
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Figure 6. Satellite repeat RNAs are involved in chromocenter reorganization during muscle differentiation. (A) Schematic of the structure of the
peri/centromeric region that consists of MajS andMinS repeats. The location of antisense oligonucleotides (ASOs) for targeting satellite RNAs is demon-
strated. (B) RT-qPCR forMajS, MinS and ChRO1 RNAs in ASO-treatedMTs (Day 3). n.s.: not significant. (C) DAPI-staining of nuclei fromMTs treated
with MajS- or MinS-specific ASOs (left). The number of chromocenters is shown at right. (D) RT-qPCR for MyHC andMCK inMajS- or MinS-depleted
MTs (Day 3). (E) RNA-FISH for ChRO1 in MajS- or MinS-ASO treated MTs (Day 3). (F) Schematic of ChRO1-mediated large-scale reorganization of
constitutive heterochromatin during myogenesis.
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and Swi6/HP1 to pericentromeres via RITS (RNA-induced
transcriptional silencing) complex (57). Although the con-
tribution of yeast-like RNAi system is less clear in higher
eukaryotes, satellite RNAs are still critical players in
PCH/CH formation, as they promote stable association of
Suv39H1/2 and HP1 at these regions through RNA:DNA
and RNA:protein interaction (12,58,59). In higher eu-
karyotes, variant histone H3.3 is essential for pol II-
dependent satellite RNA transcription, and crucial for
co-transcriptional silencing of these regions (13,54,60,61).
From the observation that chromocenter clustering was ac-
companied by robust induction of satellite RNAs, these re-
peat RNAs are likely excellent players for large-scale chro-
matin compaction, by hosting a broader range of chro-
matin factors, in addition to SUV39H/HP1. A recent re-
port on the engagement of satellite RNAs in the clustering
of pericentromeres into chromocenters during development
further supports our hypothesis (62). In this regard, it is
noteworthy that ChRO1 contributes to the amplification of
satellite RNAs at the transcriptional level, in part by com-
plementing an RNAi-mediated heterochromatin silencing
pathway (18). However, to understand the detailed mech-
anisms in chromocenter clustering, a full list of satellite
RNA- and ChRO1-interacting factors must be provided.
Constitutive heterochromatin reorganization occurs dur-
ing cellular differentiation process, and is expected to dra-
matically affect the nuclear environment of many develop-
mentally associated genomic loci. However, it is still unan-
swered whether heterochromatin reorganization is a cause,
or a consequence, of cell differentiation or gene regulation.
Regarding this, our data demonstrate that PCH/CH reor-
ganization caused by ChRO1/ATRX/DAXX/H3.3 is criti-
cal for muscle gene activation and myoblast differentiation,
although the detailed mechanism of how heterochromatin
reorganization affects muscle differentiation or gene regula-
tionmust be provided. Collectively, our study sheds light on
the regulatory mechanism of the differentiation-associated
large-scale heterochromatin formation through the identifi-
cation of ChRO1.
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